It seems appropriate that the Cold Spring Harbor Genome Sequencing and Biology Meeting, which witnessed the creation of the Human Genome Organization (HUGO) in 1988, should this year present three major advances in genomic science: the completion of the ®nished sequence of Drosophila melanogaster; the announcement that 85% of the genome of Homo sapiens is now in draft sequence; and the complete, ®nished sequence of a second human chromosome, chromosome 21. Other major sessions of the meeting focused on single nucleotide polymorphisms (SNPs), ethical, legal and social implications (ELSI), as well as comparative and functional genomics.
There is signi®cant debate as to whether the technique of`whole genome shotgun' sequencing 1 is applicable to the elucidation of larger genomes (e.g. human). Prior to the beginning of this year, this technique had only been demonstrated on small microbial genomes (such as Haemophilus in¯uenzae, with a genome of approximately 1.8 Mb [1] ) and there had been considerable scepticism as to whether the technique would work in human or fruit¯y. There was, therefore, considerable interest and excitement in the presentation by the Berkeley Drosophila Genome Project (BDGP) and Celera Genomics (Rockville, USA) on the full Drosophila sequence.
The crux of the whole-genome shotgun strategy is the assembly technique. Gene Myers (Celera Genomics) reported on how the`double-barrelled' shotgun 2 approach had given a signi®cant advantage to the computer algorithms employed in the assembly of the¯y genome. The assembly system employs a bottom-up, nucleating strategy, initially assembling small islands of sequence of high con®dence (diverting the assembly of repeat regions to later stages) and then searching for other sequence (including orientation data from clone endsequencing) to join the islands together. In addition, he con®rmed a less than 0.5% error rate in the automated assembly of repeat sequences that are a potential problem for this type of system. Gerry Rubin (BDGP) and Mark Adams (Celera Genomics) presented material from the analysis of the genomic sequence, showing that the total number of genes is approximately 13 600 (compared with approximately 15 000 seen in the smaller 100 Mb Caenorhabditis elegans genome). In addition, there was substantial variation of 0±30 genes per 50 kb (but without the clustering seen in C. elegans). There was also a general trend showing a marked decrease in gene density, G+C content and an increase in transposons in the 1 Mb portion adjacent to the centromeric heterochromatin. Gerry Rubin commented that it was remarkable that thē y had only just over twice the number of genes compared with yeast, leading to the proposition that the complexity of an organism's gene content is not directly proportional to the complexity of the organism itself.
This observation prompted spirited debate, centred on exactly how many genes would comprise the human genome and, indeed, how one would de®ne what comprised a single gene. In
In addition to the announcement of the completion Drosophila genome, substantial progress has been achieved in the production of the working draft of the human genome. Jane Rogers (Sanger Centre, UK) presented the accelerated progress of the draft sequencing, now representing 85% of the human genome, with anything up to 97% in the ®nal phase of checking (http://www.sanger.ac.uk/ HGP/stats.shtml).
Andre Â Rosenthal (Institut fu È r Molekulare Biotechnologie, Germany) reported the work of an international consortium of labs [2] producing a ®nished sequence for human chromosome 21. This chromosome has almost 20 disease loci associated with it, in addition to the trisomy that gives rise to Down's syndrome. From the analysis of the ®nished sequence, the consortium identi®ed 127 genes of known function and 98 putative genes (including 59 pseudogenes). Approximately 40% of this chromosome is composed of repetitive elements, with some apparently very gene-poor areas totalling approximately 10 Mb. One of the most startling of the gene-poor regions was a 7 Mb region on 21q, where only one gene, as yet, has been detected. Using the number of genes identi®ed from the completed sequence from human chromosomes 21 and 22, an extrapolation was done showing that (theoretically) the human genome could contain as little as 40 000 genes.
In addition to the intense experimental effort, several sessions focused on the bioinformatics techniques being designed to analyse the explosion of raw data from the sequencing and mapping centres. One of the principal problems with the high output of the various genome projects concerns the degree and appropriateness of annotation assigned to a sequence. This is exacerbated by the constantly evolving draft sequence. Ewan Birney (EBI, UK) presented the Ensembl (http://www.ensembl.org/) system, which is capable of de®ning features on draft sequence (assigning them stable identi®ers), maintaining those features and identi®ers as draft sequence progresses to its ®nal ®nished form. This system is clearly a valuable tool in the early identi®cation and exploitation of novel genes and regulatory elements. Comparative sequence analysis 3 is also becoming a viable tool for the dissection of novel genomic regions where sequence is available in a number of species. Greg Elgar (Human Genome Project Resource Centre, UK) presented comparative analysis between the compressed genome of the puffer-®sh, Fugu, with a number of loci in mouse and man, demonstrating the power of this technique in identifying new genes and conserved regions in these species. In addition, to aid this type of approach, tools are being developed to align and visualize multi-species sequence comparisons, e.g. the Vista tool (Kelly Frazer, Lawrence Berkley National Laboratory, USA). This tool is capable of visualizing long-range alignments between several species and can be used to de®ne statistical cut-offs for conserved elements.
The keynote speech was, appropriately, delivered by Francis Collins (National Human Genome Research Institute, USA), who has played a pivotal role in the organisation of the Human Genome Project and who clearly relished the prospect of delivering this address. He urged the assembled audience not to lose sight of the ultimate goals of the genome project; in the near-term this means the generation of high-quality, annotated sequence, that is made available to all. In the longer term, the requirement is to begin to use the data generated to pump-prime the next phase of genomic science ± seeing that this, in turn, is translated into advances in basic medical science.
Given the potential impact of even the draft sequence on the whole of science and society, Dr
